Open Access Opinion Article ID: APRC-6-155

    The use of aerosolized - Adrenergic agonist therapy after lung transplantation in pediatric age

    Giorgia Grutter* and Zaccaria Ricci

    It is my opinion the use of aeresolized –adrenergic agonist such as salbutamol may be helpfull  not only  to reduced the early mortality but also  the chronic allograft dysfunction  after lung transplantation in children The reduction of pulmonary  edema could be prevent the induction of Obstructive Bronchiolites Syndrome (less pneumonia  and viral infections etc) such as the primary graft dysfunction.As we know by international literature Lung transplantation continues to suffer from less-than-ideal long-term outcomes, even in pediatric patients.


    Published on: Jun 29, 2020 Pages: 58-59

    Full Text PDF Full Text HTML DOI: 10.17352/aprc.000055
    CrossMark Publons Harvard Library HOLLIS Search IT Semantic Scholar Get Citation Base Search Scilit OAI-PMH ResearchGate Academic Microsoft GrowKudos Universite de Paris UW Libraries SJSU King Library SJSU King Library NUS Library McGill DET KGL BIBLiOTEK JCU Discovery Universidad De Lima WorldCat VU on WorldCat


    Global Views

    Case Reports

    Peertechz Tweets

    Pinterest on APRC

    Google Reviews 11